Literature DB >> 28000699

Absence of Hikeshi, a nuclear transporter for heat-shock protein HSP70, causes infantile hypomyelinating leukoencephalopathy.

Catalina Vasilescu1, Pirjo Isohanni1,2, Maarit Palomäki3, Helena Pihko2, Anu Suomalainen1,4,5, Christopher J Carroll1.   

Abstract

Genetic leukoencephalopathies are a heterogeneous group of central nervous system disorders with white matter involvement. In a Finnish patient, we identified a novel homozygous disease-causing variant in HIKESHI, c.11G>C, p.(Cys4Ser), leading to hypomyelinating leukoencephalopathy with periventricular cysts and vermian atrophy. A founder Ashkenazi-Jewish disease-causing variant recently linked Hikeshi and its heat-shock protective function to leukoencephalopathy. In our patient, clinical features of lower limb spasticity, optic atrophy, nystagmus, and severe developmental delay were similar to reported patients. Additional features included vermian atrophy, epileptic seizures, and an ovarian tumor. Structural modeling and protein analyses revealed that modified interactions inside Hikeshi's hydrophobic pockets induce protein instability. The patient's cells showed impaired nuclear translocation of HSP70 during heat shock, and decreased ERO1-Lα, an endoplasmic reticulum (ER) oxidoreductase. Overall, we show that: (1) the clinical spectrum associated with Hikeshi deficiency extends to leukoencephalopathy with vermian atrophy and epilepsy; (2) the cellular disease process involves both nuclear chaperone and ER functions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28000699      PMCID: PMC5315520          DOI: 10.1038/ejhg.2016.189

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  19 in total

1.  Hikeshi, a nuclear import carrier for Hsp70s, protects cells from heat shock-induced nuclear damage.

Authors:  Shingo Kose; Maiko Furuta; Naoko Imamoto
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

Review 2.  Case definition and classification of leukodystrophies and leukoencephalopathies.

Authors:  Adeline Vanderver; Morgan Prust; Davide Tonduti; Fanny Mochel; Heather M Hussey; Guy Helman; James Garbern; Florian Eichler; Pierre Labauge; Patrick Aubourg; Diana Rodriguez; Marc C Patterson; Johan L K Van Hove; Johanna Schmidt; Nicole I Wolf; Odile Boespflug-Tanguy; Raphael Schiffmann; Marjo S van der Knaap
Journal:  Mol Genet Metab       Date:  2015-01-29       Impact factor: 4.797

3.  Structural and functional analysis of Hikeshi, a new nuclear transport receptor of Hsp70s.

Authors:  Jinsue Song; Shingo Kose; Ai Watanabe; Se Young Son; Saehae Choi; Hyerim Hong; Eiki Yamashita; Il Yeong Park; Naoko Imamoto; Soo Jae Lee
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-02-26

Review 4.  Nucleocytoplasmic transport under stress conditions and its role in HSP70 chaperone systems.

Authors:  Shingo Kose; Naoko Imamoto
Journal:  Biochim Biophys Acta       Date:  2014-05-02

5.  Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition.

Authors:  K M Davey; J S Parboosingh; D R McLeod; A Chan; R Casey; P Ferreira; F F Snyder; P J Bridge; F P Bernier
Journal:  J Med Genet       Date:  2005-07-31       Impact factor: 6.318

6.  DNAJC13 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alex Rajput; Austen J Milnerwood; Brinda Shah; Chelsea Szu-Tu; Joanne Trinh; Irene Yu; Mary Encarnacion; Lise N Munsie; Lucia Tapia; Emil K Gustavsson; Patrick Chou; Igor Tatarnikov; Daniel M Evans; Frederick T Pishotta; Mattia Volta; Dayne Beccano-Kelly; Christina Thompson; Michelle K Lin; Holly E Sherman; Heather J Han; Bruce L Guenther; Wyeth W Wasserman; Virginie Bernard; Colin J Ross; Silke Appel-Cresswell; A Jon Stoessl; Christopher A Robinson; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Rachel A Gibson; Peter S McPherson; Martine Girard; Michele Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

7.  Leukoencephalopathy and early death associated with an Ashkenazi-Jewish founder mutation in the Hikeshi gene.

Authors:  Simon Edvardson; Shingo Kose; Chaim Jalas; Aviva Fattal-Valevski; Ai Watanabe; Yutaka Ogawa; Hiroshi Mamada; Anastasia M Fedick; Shay Ben-Shachar; Nathan R Treff; Avraham Shaag; Sherri Bale; Jutta Gärtner; Naoko Imamoto; Orly Elpeleg
Journal:  J Med Genet       Date:  2015-11-06       Impact factor: 6.318

8.  New mutation of mitochondrial DNAJC19 causing dilated and noncompaction cardiomyopathy, anemia, ataxia, and male genital anomalies.

Authors:  Tiina Ojala; Padmini Polinati; Tuula Manninen; Anita Hiippala; Jukka Rajantie; Riitta Karikoski; Anu Suomalainen; Tiina Tyni
Journal:  Pediatr Res       Date:  2012-07-13       Impact factor: 3.756

Review 9.  Chaperones in Neurodegeneration.

Authors:  Iris Lindberg; James Shorter; R Luke Wiseman; Fabrizio Chiti; Chad A Dickey; Pamela J McLean
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

10.  A deleterious mutation in DNAJC6 encoding the neuronal-specific clathrin-uncoating co-chaperone auxilin, is associated with juvenile parkinsonism.

Authors:  Simon Edvardson; Yuval Cinnamon; Asaf Ta-Shma; Avraham Shaag; Yang-In Yim; Shamir Zenvirt; Chaim Jalas; Suzanne Lesage; Alexis Brice; Albert Taraboulos; Klaus H Kaestner; Lois E Greene; Orly Elpeleg
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more
  4 in total

1.  Lack of Hikeshi activates HSF1 activity under normal conditions and disturbs the heat-shock response.

Authors:  Shingo Kose; Kenichiro Imai; Ai Watanabe; Akira Nakai; Yutaka Suzuki; Naoko Imamoto
Journal:  Life Sci Alliance       Date:  2022-05-17

2.  The Infantile Leukoencephalopathy-Associated Mutation of C11ORF73/HIKESHI Proteins Generates de novo Interactive Activity with Filamin A, Inhibiting Oligodendroglial Cell Morphological Differentiation.

Authors:  Kohei Hattori; Kenji Tago; Shiori Memezawa; Arisa Ochiai; Sui Sawaguchi; Yukino Kato; Takanari Sato; Kazuma Tomizuka; Hiroaki Ooizumi; Katsuya Ohbuchi; Kazushige Mizoguchi; Yuki Miyamoto; Junji Yamauchi
Journal:  Medicines (Basel)       Date:  2021-02-01

3.  Classifying Hypomyelination: A Critical (White) Matter.

Authors:  Stefanie Perrier; Sara Matovic; Geneviève Bernard
Journal:  Child Neurol Open       Date:  2020-12-24

4.  Further Delineation of the Clinical and Pathologic Features of HIKESHI-Related Hypomyelinating Leukodystrophy.

Authors:  Guy Helman; Ayelet Zerem; Akshata Almad; Julia L Hacker; Sarah Woidill; Sunetra Sase; Alexandra N LeFevre; Josef Ekstein; Martin M Johansson; Chloe A Stutterd; Ryan J Taft; Cas Simons; Judith B Grinspan; Amy Pizzino; Johanna L Schmidt; Brian Harding; Yoel Hirsch; Angela N Viaene; Aviva Fattal-Valevski; Adeline Vanderver
Journal:  Pediatr Neurol       Date:  2021-05-14       Impact factor: 4.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.